ANEMOCYTE
LIVE

Serial Number

79404747

Owner

ANEMOCYTE S.R.L.

Attorney

Brian A. Tollefson

Filing Date

Feb 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ANEMOCYTE Trademark

Serial Number: 79404747

ANEMOCYTE is a trademark filed by ANEMOCYTE S.R.L. on February 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ANEMOCYTE S.R.L. (5 trademarks)

Via R. Lepetit, 34

Entity Type: 16

Trademark Details

Filing Date

February 20, 2024

Registration Date

Not Registered

Goods & Services

Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines for dental purposes; chemical preparations for pharmaceutical or medical purposes, namely for oncology and immuno-oncology, respiratory, infectious diseases, flu, covid, cardiovascular, dermatology, rare diseases, metabolic diseases; biological preparations for the treatment of cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; biological reagents for medical purposes; vaccines; nucleic acid sequences for medical and veterinary products; dietetic foods adapted for medical use; antibodies for medical purposes; dietary supplements; pharmaceutical preparations for treating diabetes; diagnostic preparations for medical purposes; Biolofical tissue cultures fo rmedical use

Research and development of vaccines and medicines; scientific and technological services Scientific and technological services, namely manufacturing, scientific research, innovation and development, process development, analysis, testing, storage, stability studies, regulatory support in the field of cell and gene therapies, DNA and RNA; Research and development services in the field of medical preparations; medical research laboratories; design and development of computer hardware and computer software; scientific research; research and development services of new pharmaceutical products.

Medical instruments for cutting tissue; Surgical apparatus and instruments for medical, dental or veterinary use; Medical devices for use in treating or cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; Electro-surgical motors being part of surgical and medical apparatus and instruments for use in general surgery

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 5, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 18, 2026 OPNR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 3, 2025 ZZZX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 25, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2025 TROA
REFUSAL PROCESSED BY IB
Dec 29, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 9, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 23, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 20, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 20, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 19, 2024 REPR